PlainRecalls
FDA Drug Moderate Class II Terminated

Sufentanil Citrate PF 90 mcg/mL/Clonidine HCL PF 500 mcg/mL/Bupivacaine HCL PF 12.8 mg/mL, Compounded, 20 mL Syringe, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.

Reported: December 18, 2019 Initiated: September 3, 2019 #D-0599-2020

Product Description

Sufentanil Citrate PF 90 mcg/mL/Clonidine HCL PF 500 mcg/mL/Bupivacaine HCL PF 12.8 mg/mL, Compounded, 20 mL Syringe, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.

Reason for Recall

Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.

Details

Units Affected
Unknown
Distribution
Nationwide in the U.S.
Location
Tampa, FL

Frequently Asked Questions

What product was recalled?
Sufentanil Citrate PF 90 mcg/mL/Clonidine HCL PF 500 mcg/mL/Bupivacaine HCL PF 12.8 mg/mL, Compounded, 20 mL Syringe, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.. Recalled by Coast Quality Pharmacy, LLC dba Anazao Health. Units affected: Unknown.
Why was this product recalled?
Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 18, 2019. Severity: Moderate. Recall number: D-0599-2020.